Trojan Bio

Harnessing viral specific immunity for fighting cancer

Yavne, Israel · Founded 2021

Headquarters
Yavne
Employees
1–10
Founded
2021
Business Model
B2B
Last Round
GrantJan 2023
Rounds
3

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

Trojan Bio is developing a novel class of therapeutic antibodies for the treatment of solid tumors. The company's Trojan antibody platform integrates viral peptides into antibody structures, enabling them to penetrate tumor microenvironments and activate the immune system from within—harnessing antiviral immunity to fight cancer. Trojan Bio won the Biomed Israel 2025 Startup Competition and is backed by Peregrine Ventures.

Summary

Trojan Bio is a Biotech company based in Yavne, Israel, founded in 2021. Its most recent funding was a Grant round in Jan 2023. Investors include NFX, Peregrine Ventures and Israel Innovation Authority.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Grant2023 (est.)

Sign up to see all 3 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trojan Bio on Indexed.vc
<a href="https://indexed.vc/companies/trojan-bio"><img src="https://indexed.vc/api/badge/company/trojan-bio" alt="Trojan Bio on Indexed.vc" width="260" height="76" /></a>